Related references
Note: Only part of the references are listed.Reporting of prognostic studies of tumour markers: a review of published articles in relation to REMARK guidelines
S. Mallett et al.
BRITISH JOURNAL OF CANCER (2010)
International Efforts to Develop Biospecimen Best Practices
Jimmie B. Vaught et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
The Clinical Plasma Proteome: A Survey of Clinical Assays for Proteins in Plasma and Serum
N. Leigh Anderson
CLINICAL CHEMISTRY (2010)
Sources of Bias in Specimens for Research About Molecular Markers for Cancer
David F. Ransohoff et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality and Re-Infarction in Consecutive Patients With Suspected Acute Coronary Syndrome Who Are Troponin-Negative
Karthik Viswanathan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)
Banking of clinical samples for proteomic biomarker studies: A consideration of logistical issues with a focus on pre-analytical variation
David H. Jackson et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
When do new biomarkers make economic sense?
Mitchell G. Scott
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Novel markers, a payer's perspective: Commissioning a new service
Christopher P. Price et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Assessing the impact of biomarkers on patient outcome: An obligatory step
David E. Bruns et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Development of novel IVD assays: A manufacturer's perspective
Thomas A. Metcalfe
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Foreword
Mauro Panteghini
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Qualification versus validation of biomarkers
Jenny Doust
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2010)
Criteria for Evaluation of Novel Markers of Cardiovascular Risk
Mark A. Hlatky et al.
CIRCULATION (2009)
Managing demand for pathology tests: financial imperative or duty of care?
Anthony A. Fryer et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
The rise and fall of C-reactive protein: managing demand within clinical biochemistry
H. D. Hutton et al.
ANNALS OF CLINICAL BIOCHEMISTRY (2009)
Ten steps towards improving prognosis research
Harry Hemingway et al.
BRITISH MEDICAL JOURNAL (2009)
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Clinical Practice: Quality Requirements
Catharine M. Sturgeon et al.
CLINICAL CHEMISTRY (2008)
The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine
Paul Elliott et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2008)
How to improve reliability and efficiency of research about molecular markers: roles of phases, guidelines, and study design
David F. Ransohoff
JOURNAL OF CLINICAL EPIDEMIOLOGY (2007)
Standardization of FSH, LH and hCG - Current position and future prospects
C. M. Sturgeon et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
Proteomics: A new diagnostic frontier
GL Hortin et al.
CLINICAL CHEMISTRY (2006)
Usage of troponin in the real world: a lesson for the introduction of biochemical assays
K Rajappan et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2005)
Changing clinical behaviour by making guidelines specific
S Michie et al.
BRITISH MEDICAL JOURNAL (2004)
Inherent biological variation and reference values
CG Fraser
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2004)
Assessing the clinical impact of prostate-specific antigen assay variability and nonequimolarity: A simulation study based on the population of the United Kingdom
AW Roddam et al.
CLINICAL CHEMISTRY (2004)
Evidence base of clinical diagnosis - The architecture of diagnostic research
DL Sackett et al.
BRITISH MEDICAL JOURNAL (2002)
Share Paper
